Global trends in pharma machinery
A recent VDMA Symposium showcased global trends. An Express Pharma report
In the past few years, Indian pharmaceutical companies have been increasing their focus on international markets, in order to improve valuations. Thus, many Indian pharmaceutical manufacturing plants have been fitted out with sophisticated machinery, in order to ease regulatory clearances in regulated markets. Indian pharmaceutical manufacturers are, therefore, very keen to keep up with global trends.
Jens-Uwe Roestel, Managing Director, KORSCH Asia Pacific, says, “In today’s development at pharmaceutical companies, more and more is about drug delivery options in tablets. To be able to implement this feature into tablets you need special designs, e.g. layered tablets of two to five layers in one tablet, or tablet in tablet, corecoating, formerly known as dry coating. Korsch has developed technologies, which make tablet presses flexible to be used for one to three layered tablets or core coated tablets in a normal standard mach-ine and only modules have to be exchanged. This gives the users the advantage, that they can develop very special tablets without the requirements to invest into very special type of tablet presses.”
In keeping with these trends, tabletting machines of the 21st century are bound to look very different. Roestel predicts three trends visible today, “Ultra flexible modular build machines for almost all possible application will be seen.” Secondly, contained machines for the production of high potent drugs will have a much bigger market share. “And we will see small machines for very flexible extreme small batch productions.
For customer designed drugs. That means every tablet will be formulated for the requirement of exactly one customer. This will become a very important, but also complex and complicated field,” he concludes.
Other trends are also visible. Stephan Mies, General Manager, Korsch, pointed out that the incorporation of Cleaning In Place (CIP) systems, which is vital for user safety and time saving is another important feature to be incorporated into pharma machinery.
Roestel and Mies were in Mumbai to participate in a Symposium on ‘German Technology for the Pharma-ceutical Industry” organised by VDMA, the German Engineering Federation in Mumbai recently.
The time seems right for such symposiums. Dr Peter Golz, Deputy Managing Director, VDMA pointed out that previously, the Indian machinery market used to be a closed market, due to high import duties, but this has improved as the Indian economy is opening up to focus on international markets. Rajesh Nath, Managing Director of the Indian office of VDMA, said that the response to the Symposium has been good.